课题基金 / 基金详情

IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS

IMMORTALIZATION OF SV40-TRANSFORMED HUMAN CELLS
SV40 转化人类细胞的永生化
批准号:
2048911
负责人:
HARVEY L OZER
金额:
$29.36万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-12-01 至 1997-07-31

项目摘要

项目成果

HARVEY L OZER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the applicant's abstract): Human diploid cells derived from normal tissue undergo a characteristic pattern of growth in cell culture, ending with a non-replicative phase. Models of cellular aging have been developed which suggest analogy between this pattern and behavior of the organism in vivo; hence, the term senescence. Human diploid fibroblasts (HF) which have been transformed in vitro by the DNA virus SV40 have been found to overcome this phenomenon (i.e., immortalize) at low frequency. The investigators have isolated a series of SV40- transformed HF using origin-defective viral genomes containing either a wild-type T antigen (SV/HF) or that of tsA58 (SVtsA/HF). In each system, they have subsequently isolated immortalized derivatives for comparative studies. The data are most consistent with a 2-step model for immortalization. SV40 large T antigen(LT) function is required in both stages, as demonstrated by temperature-dependent (ts) cell proliferation in concordance with ts LT function in preimmortal and immortal SVtsA/HF-A cells. At step 1, LT functions as a mitogenic agent, in large part through its interaction with cellular proteins as pRb and p53. Step 2, which is specific to immortalization, involves changes in functions not directly dependent on LT. A rearrangement on the long arm of chromosome 6 (6q21) consistent with inactivation of a suppressor gene has been found to be specifically associated with step 2. The applicant has identified changes in gene expression through differential hybridization with cDNA libraries of preimmortal and immortal SV40- transformants and propose to identify the genes involved. The investigator will focus initially on those genes whose expression is reduced in several matched immortal transformants as compared to their parental preimmortal transformants, most consistent with the recessive nature of the latter in cell hybrids. Strategies are also presented to identify the responsible gene on 6q. In both cases, the genes identified will be assessed for growth suppression of immortal cell lines, a phenomenon relevant to both senescence and carcinogenesis. The investigators have also found that the cellular proto-oncogene c-myb is induced in an immortal HF cell line transformed by an intact but not a truncated LT. They propose to assess the viral and cellular functions responsible because of the importance of c-myb to cell proliferation and as a prototype of genes overexpressed in immortal SV40-transformants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interdisciplinary Training Program in Cancer Research
Interdisciplinary Training Program in Cancer Research
Interdisciplinary Training Program in Cancer Research
  • 批准号:
    8701009
  • 项目类别:
  • 资助金额:
    $6.57万
  • 财政年份:
    2010
  • 负责人:
    HARVEY L OZER
  • 依托单位:
Interdisciplinary Training Program in Cancer Research
国内基金
海外基金
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: